Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation.
Bailén R, Kwon M, Pascual-Cascón MJ, Ferrà C, Sanz J, Gallardo-Morillo A, García-Sola A, Torrent A, Jiménez-Lorenzo MJ, Piñana JL, Montoro J, Oarbeascoa G, Dorado N, Gómez-Centurión I, Muñoz C, Martínez-Laperche C, Anguita J, Buño I, Díez-Martín JL; Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH).
Bailén R, et al. Among authors: munoz c.
Ann Hematol. 2021 Feb;100(2):541-553. doi: 10.1007/s00277-020-04317-7. Epub 2020 Nov 2.
Ann Hematol. 2021.
PMID: 33140137
Clinical Trial.